Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy Of Abbreviated Induction With Only 4 Cycles Of Fludarabine (F), Cyclophosphamide (C) and Rituximab (R) In Physically Fit Patients With Chronic Lymphocytic Leukemia (CLL) Who Achieve Early Complete Remission (CR) With Undetectable Minimal Residual Disease (MDR)

Carolina Pavlovsky, Astrid Pavlovsky, Isolda Fernandez, Adriana Galeano, Francisco Lastiri, Santiago Pavlovsky

Blood (2013) 122 (21): 2886.

https://doi.org/10.1182/blood.V122.21.2886.2886

Published: 2013

Journal Articles

PET -CT Adapted Therapy After 3 Cycles of ABVD for All Stages of Hodgkin Lymphoma. Preliminary Results in 193 Patients

Astrid Pavlovsky, Isolda Fernandez, Virginia Prates, Miguel A Pavlovsky, Lucia Zoppegno, Ana Lisa Basquiera, Federico Sackmann, Francisco Lastiri, Gustavo Milone, Santiago Pavlovsky

Blood (2011) 118 (21): 1619.

https://doi.org/10.1182/blood.V118.21.1619.1619

Published: 2011

Journal Articles

PET-CT Adapted Therapy After 3 Cycles of ABVD for All Stages of Hodgkin Lymphoma. Interim Analysis in 173 Patients

Santiago Pavlovsky, Astrid Pavlovsky, Isolda Fernandez, Miguel Pavlovsky, Virginia Prates, Lucia Zoppegno, Ana Lisa Basquiera, Ider Cerutti, Andrea Rodriguez, Gustavo Milone, Vanesa Castano, Silvia Rudoy, Federico Sackmann, Lourdes Valles, Francisco Lastiri

Blood (2010) 116 (21): 1772.

https://doi.org/10.1182/blood.V116.21.1772.1772

Published: 2010

Journal Articles

Impact of FISH and Cytogenetics On Overall and Event Free Survival in Myeloma: An IMWG Analysis of 9,897 Patients.

Blood (2009) 114 (22): 743.

https://doi.org/10.1182/blood.V114.22.743.743

Published: 2009

Journal Articles

Monitoring Minimal Residual Disease by Quantitative PCR in Chronic Myeloid Leukemia Patients in Complete Cytogenetic Remission

Blood (2008) 112 (11): 4272.

https://doi.org/10.1182/blood.V112.11.4272.4272

Published: 2008

Journal Articles

Evaluation of Prognostic Factors for Malignant Transformation of Monoclonal Gammopathy of Undetermined Significance

Federico Sackmann, Claudia Corrado, Isolda Fernandez, Miguel A Pavlovsky, Pablo Mountford, Astrid Pavlovsky, Miguel Pavlovsky, Mariel Alejandre, Marco Pizzolato, Santiago Pavlovsky, MD, PhD

Blood (2008) 112 (11): 5123.

https://doi.org/10.1182/blood.V112.11.5123.5123

Published: 2008

Journal Articles

Prospective Evaluation of the International Prognostic Score (IPS) in All Stages of Hodgkin’s Lymphoma Treated with ABVD Plus Involved-Field Radiotherapy (IFRT).

Santiago Pavlovsky, Claudia Corrado, Miguel A Pavlovsky, Virginia Prates, Lucia Zoppegno, Mario Giunta, Ider Cerutti, Elsa Palomino, Graciela Avila, Francisco Lastiri

Blood (2008) 112 (11): 1454.

https://doi.org/10.1182/blood.V112.11.1454.1454

Published: 2008

Journal Articles

PET-CT Adapted Therapy after 3 Cycles of ABVD for All Stages of Hodgkin Lymphoma. Interim Analysis. Preliminary Results in 102 Patients

Astrid Pavlovsky, Santiago Pavlovsky, Isolda Fernandez, Lucia Zoppegno, Ider Cerutti, Miguel Arturo Pavlovsky, Virginia Prates, Ana Basquiera, Claudia Corrado, Gustavo Milone, Maria Cabrejo, Horacio Fernandez Grecco, Graciela Avila, Viviana Flores Dutrus, Karina Gumpel, Vanina Cabanne, Silvia Saba, Francisco Lastiri

Blood (2008) 112 (11): 2592.

https://doi.org/10.1182/blood.V112.11.2592.2592

Published: 2008

Journal Articles

Monitoring Response to Imatinib by Fluorescence In Situ Hybridization (FISH) and Real-Time Quantitative Polymerase Chain Reaction (RQ-PCR) in Chronic Myeloid Leukemia (CML) Patients in Chronic Phase. Experience of Argentina and Uruguay.

Blood (2006) 108 (11): 4766.

https://doi.org/10.1182/blood.V108.11.4766.4766

Published: 2006

Journal Articles

Acquired Mutations in the BCR-ABL Kinase Domain in Imatinib Resistant Patients. Multicentric Experience in Argentina and Uruguay.

Blood (2006) 108 (11): 4811.

https://doi.org/10.1182/blood.V108.11.4811.4811

Published: 2006

Journal Articles

Therapy with Fludarabine, Cyclophosphamide and Rituximab (FCR) for Relapsed or Untreated Progressive Chronic Lymphocytic Leukemia (CLL). A Single Center Experience.

Carolina Pavlovsky, MD, Santiago Pavlovsky, MD PhD, Maria L. Pardo, MD, Sandra Sapia, MD, Mariela Monreal, MD, Claudia Corrado, MDd, Miguel A. Pavlovsky, MD, Isolda Fernandez, MD, Mariana Juni, MS

Blood (2006) 108 (11): 4968.

https://doi.org/10.1182/blood.V108.11.4968.4968

Published: 2006

Journal Articles

Risk-Oriented Therapy in Adults Previously Untreated Hodgkin’s Lymphoma (HL) with ABVD Followed by Involved Field Radiotherapy (IFRT). Final Results of the Argentinian Group for Treatment of Acute Leukemia (GATLA) Phase III Study.

Santiago Pavlovsky, MD, PhD, Claudia S. Corrado, MD, Miguel A. Pavlovsky, MD, Virginia Prates, MD, Lucia Zoppegno, MD, Mario Giunta, MD, Ider Cerutti, MD, Elsa Palomino, MD, Fernando Pagani, MD, Francisco Lastiri, MD, Maria C. Narbaitz, MD, Fernando Cavagnaro, MD, Graciela Avila, MD

Blood (2006) 108 (11): 2474.

https://doi.org/10.1182/blood.V108.11.2474.2474

Published: 2006

Journal Articles

Impact of FLT3 Mutational Status as Prognostic Factor in Acute Myeloid Leukemia Patients from Argentina and Uruguay.

Isabel Giere, PhD, Angel Chacon, MD, Rosario Uriarte, PhD, Virginia Lombardi, PhD, Isolda Fernandez, MD, Fernanda Garcia Reinoso, Ph.D, Rosana Bonomi, MD, Maria Zubillaga, PhD, Hugo Giordano, MD, Laura Pardo, PhD, Sandra Sapia, MD, Mariela Monreal, Ph.D, Lem Martinez, MD, Santiago Pavlovsky, MD, PhD

Blood (2005) 106 (11): 4494.

https://doi.org/10.1182/blood.V106.11.4494.4494

Published: 2005

Journal Articles

Combined Chemotherapy with Fludarabine, Cyclophosphamide and Rituximab (FCR) for Relapsed or Untreated Progressive Chronic Lymphocytic Leukemia (CLL). A Single Center Experience.

Santiago Pavlovsky, MD, PhD, Carolina Pavlovsky, MD, Laura Pardo, MD, Sandra Sapia, MD, Isolda I. Fernandez, MD, Mariana Juni

Blood (2005) 106 (11): 5033.

https://doi.org/10.1182/blood.V106.11.5033.5033

Published: 2005

Journal Articles

Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry

Blood (2004) 104 (12): 3797–3803.

https://doi.org/10.1182/blood-2004-01-0231

Published: 2004

Journal Articles

CD38 Expression Has an Important Value among Prognostic Factors in Chronic Lymphocytic Leukemia (CLL): A Multivariate Analysis in 160 Patients.

Carolina Pavlovsky, MD, Miguel A. Pavlovsky, MD, Maria L. Pardo, MD, Sandra Sapia, MD, Pablo Mountford, MD, Isolda I. Fernandez, MD, Claudia S. Corrado, MD, Mariana Juni Statistics, Santiago Pavlovsky, MD PhD

Blood (2004) 104 (11): 4779.

https://doi.org/10.1182/blood.V104.11.4779.4779

Published: 2004

Journal Articles

Risk-Adapted Therapy in Adults Previously Untreated Hodgkin’s Lymphoma (HL) with ABVD Followed by Involved Field Radiotherapy (IFRT).

Santiago Pavlovsky, MD PhD, Claudia S. Corrado, MD, Miguel A. Pavlovsky, MD, Mario Giunta, MD, Lucia Zoppegno, MD, Virginia Prates, MD, Francisco Lastiri, PhD, Ider Cerutti, MD, Maria C. Narbaitz, MD, Silvia Rudoy, MD, Fernando Cavagnaro, MD, Alejandra Kurchan, MD, Elsa Palomino, MD, Cesar Campo, MD

Blood (2004) 104 (11): 1310.

https://doi.org/10.1182/blood.V104.11.1310.1310

Published: 2004

Journal Articles

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma

Blood (2003) 102 (10): 3521–3529.

https://doi.org/10.1182/blood-2003-04-1205

Published: 2003

Journal Articles

Factors That Influence the Appearance of Central Nervous System Leukemia

Santiago Pavlovsky, M.D., Mariana Eppinger-Helft, M.D., Federico Sackmann Muriel, M.D.

Blood (1973) 42 (6): 935–938.

https://doi.org/10.1182/blood.V42.6.935.935

Published: 1973

NARROW

Safety and Efficacy Of Abbreviated Induction With Only 4 Cycles Of Fludarabine (F), Cyclophosphamide (C) and Rituximab (R) In Physically Fit Patients With Chronic Lymphocytic Leukemia (CLL) Who Achieve Early Complete Remission (CR) With Undetectable Minimal Residual Disease (MDR)

PET -CT Adapted Therapy After 3 Cycles of ABVD for All Stages of Hodgkin Lymphoma. Preliminary Results in 193 Patients

PET-CT Adapted Therapy After 3 Cycles of ABVD for All Stages of Hodgkin Lymphoma. Interim Analysis in 173 Patients

Impact of FISH and Cytogenetics On Overall and Event Free Survival in Myeloma: An IMWG Analysis of 9,897 Patients.

Monitoring Minimal Residual Disease by Quantitative PCR in Chronic Myeloid Leukemia Patients in Complete Cytogenetic Remission

Evaluation of Prognostic Factors for Malignant Transformation of Monoclonal Gammopathy of Undetermined Significance

Prospective Evaluation of the International Prognostic Score (IPS) in All Stages of Hodgkin’s Lymphoma Treated with ABVD Plus Involved-Field Radiotherapy (IFRT).

PET-CT Adapted Therapy after 3 Cycles of ABVD for All Stages of Hodgkin Lymphoma. Interim Analysis. Preliminary Results in 102 Patients

Monitoring Response to Imatinib by Fluorescence In Situ Hybridization (FISH) and Real-Time Quantitative Polymerase Chain Reaction (RQ-PCR) in Chronic Myeloid Leukemia (CML) Patients in Chronic Phase. Experience of Argentina and Uruguay.

Acquired Mutations in the BCR-ABL Kinase Domain in Imatinib Resistant Patients. Multicentric Experience in Argentina and Uruguay.

Therapy with Fludarabine, Cyclophosphamide and Rituximab (FCR) for Relapsed or Untreated Progressive Chronic Lymphocytic Leukemia (CLL). A Single Center Experience.

Risk-Oriented Therapy in Adults Previously Untreated Hodgkin’s Lymphoma (HL) with ABVD Followed by Involved Field Radiotherapy (IFRT). Final Results of the Argentinian Group for Treatment of Acute Leukemia (GATLA) Phase III Study.

Impact of FLT3 Mutational Status as Prognostic Factor in Acute Myeloid Leukemia Patients from Argentina and Uruguay.

Combined Chemotherapy with Fludarabine, Cyclophosphamide and Rituximab (FCR) for Relapsed or Untreated Progressive Chronic Lymphocytic Leukemia (CLL). A Single Center Experience.

Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry

CD38 Expression Has an Important Value among Prognostic Factors in Chronic Lymphocytic Leukemia (CLL): A Multivariate Analysis in 160 Patients.

Risk-Adapted Therapy in Adults Previously Untreated Hodgkin’s Lymphoma (HL) with ABVD Followed by Involved Field Radiotherapy (IFRT).

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma

Factors That Influence the Appearance of Central Nervous System Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only